Enhertu 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26F0WB3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,734
Award facts
- Contract value 100% obligated
- $18,734.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, a targeted cancer therapeutic, valued at $18,734.10 with a firm fixed price structure. This non-set-aside delivery order, executed on October 31, 2025, is scheduled for completion by November 24, 2025, with performance centered at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical prime vendor agreement extending through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors and healthcare solutions providers, has demonstrated substantial capability in fulfilling federal medical procurement requirements through competitive awards across multiple therapeutic domains. The company serves critical federal customers including the Defense Health Agency and U.S. Coast Guard, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. This particular delivery order represents a routine transaction within the broader pharmaceutical support infrastructure that ensures military and veteran healthcare systems maintain access to specialized oncology medications and other essential pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26F0WB3?
SPE2DR26F0WB3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26F0WB3 worth?
The government has obligated $18,734 on SPE2DR26F0WB3.
Is contract SPE2DR26F0WB3 an order under another contract?
Yes. SPE2DR26F0WB3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WB3 competed?
The extent of competition for SPE2DR26F0WB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award